Suchergebnisse - "Chemogenetics"

PubPharm (712)

51

Role of Potassium Ion Channels in Epilepsy : Focus on Current Therapeutic Strategies

enthalten in: CNS & neurological disorders drug targets | 2024

von Khan, R. | Chaturvedi, P. | Sahu, P. | +4

52

Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors

enthalten in: Psychopharmacology | 2023

von Chohan, M. | Fein, H. | Mirro, S. | +2

53

Synergistic effect of chemogenetic activation of corticospinal motoneurons and physical exercise in promoting functional recovery after spinal cord injury

enthalten in: Experimental neurology | 2023

von Lin, X. | Wang, X. | Zhang, Y. | +6

54

Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia

enthalten in: Journal of neuroendocrinology | 2023

von Martin, H. | Coursan, A. | Lallement, J. | +12

55

Chemogenetic Attenuation of Acute Nociceptive Signaling Enhances Functional Outcomes Following Spinal Cord Injury

enthalten in: Journal of neurotrauma | 2023

von Kumar, P. | Stallman, J. | Kharbat, Y. | +10

56

Neurosecretory Protein GM-Expressing Neurons Participate in Lipid Storage and Inflammation in Newly Developed Cre Driver Male Mice

enthalten in: Biomedicines | 2023

von Narimatsu, Y. | Kato, M. | Iwakoshi-Ukena, E. | +4

57

Targeted Delivery of Chemogenetic Adeno-Associated Viral Vectors to Cortical Sulcus Regions in Macaque Monkeys by Handheld Injections

enthalten in: Bio-protocol | 2023

von Oyama, K. | Nagai, Y. | Minamimoto, T.

58

Reduced Activity of Glutamatergic Neurons in the Prelimbic Medial Prefrontal Cortex Underlies the Inherent Aging-Related Physiological Reduction in Social Dominance

enthalten in: The journals of gerontology. Series A, Biological sciences and medical sciences | 2023

von Shan, Q. | Lin, X. | Yu, X. | +2

59

Circuit-specific gene therapy reverses core symptoms in a primate Parkinson's disease model

enthalten in: Cell | 2023

von Chen, Y. | Hong, Z. | Wang, J. | +19

CommentIn: Nat Rev Drug Discov. 2024 Jan;23(1):20. - PMID 38049465

60

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

enthalten in: Cell reports. Medicine | 2023

von Arang, N. | Lubrano, S. | Ceribelli, M. | +20